Updated on April 15 at 1 p.m. ET
Ginger Eatman thought she was safe after getting her second COVID-19 vaccination in February. But she kept wearing her mask, using hand sanitizer and wiping down the carts at the grocery store anyway. A few weeks later, she noticed a scratchy throat.
"By Wednesday morning, St. Patrick's Day, I was sick. I had congestion — a lot of congestion — and some coughing," says Eatman, 73, of Dallas, Ga.
Her doctor thought her symptoms might be allergies. But Eatman started feeling sicker. And then she suddenly lost her sense of smell. She even tried her strong perfume. Nothing.
So Eatman got tested for the coronavirus. It came back positive.
"I was shocked. I almost cried," she says. "It was like: No, that can't be."
Eatman isn't alone in this experience. It's a long-recognized phenomenon called "vaccine breakthrough."
The Centers for Disease Control and Prevention, which is tracking these coronavirus infections that break through the vaccine's protection, told NPR on Thursday that the agency has so far received reports of about 5,800 breakthrough cases. No "unexpected patterns have been identified in case demographics or vaccine characteristics," the CDC says.
Though these sorts of breakthrough infections have been reported among people of all ages, a little more than 40% so far have been among people age 60 or older, according to the agency, and 65% of such cases have been among women. About 29% of those experiencing breakthrough infections experienced no symptoms, but 7% were hospitalized and 74 people died.
This incomplete protection that some people experience occurs to some extent with a vaccine against any disease, says Dr. Saad Omer, a vaccine researcher at Yale University, and the numbers gathered so far are in line with what's expected, the CDC says.
The three vaccines authorized for use against COVID-19 in the United States appear to be at least 94% effective at preventing severe disease and death (starting about two weeks after a person is fully vaccinated), according to data reported so far, and about 80% effective at preventing infection. But that's not 100%, Omer notes, so a relatively small number of infections despite immunization with these very effective vaccines is to be expected.
"So the bottom line is: It's expected. No need to freak out," Omer says.
So far, more than 76 million people have gotten fully vaccinated in the United States. At a recent White House briefing, Dr. Anthony Fauci of the National Institutes of Health noted that such cases of lapses in full protection still appear to be quite rare. And the deaths seem to be happening primarily among frail elderly people who have other health problems.
"There's nothing there yet that's a red flag. We obviously are going to keep an eye on that very, very carefully. But I don't see anything that changes our concept of the vaccine and its efficacy," Fauci says.
And it's definitely no reason for anyone not to get vaccinated. The opposite is true.
"It would also appear the rare infections that occur are [generally] less severe, so it would also protect us against severe disease, which is great," says Dr. Francesca Torriani, an infectious disease researcher at the University of California San Diego, who has studied breakthrough infections among health care workers.
But such cases are a reminder of why it's important for people to continue being vigilant after getting vaccinated, infectious disease experts say.
"I would encourage people to continue, once they're vaccinated, to use all the prevention measures that we've been talking about when they're outside their home, including masking and distancing and whatnot. And all of that should be active in the workplace," the CDC's director, Dr. Rochelle Walensky, said during a briefing for the press on Monday.
"Assuming you take those prevention measures in the office place and outside the home, I think you're very safe in the home," Walensky said.
Meanwhile, scientists are trying to figure out why breakthrough infections occur.
"Right now we don't have a great understanding of exactly where we're open — our sort of Achilles' heel," says Dr. Alexander Greninger, an infectious disease researcher at the University of Washington.
Is the determining factor how much virus someone is exposed to? Or maybe exposure to one of the variants that can evade the immune system?
"Is it people in the lower part of the vaccine response mixing with the variants? I think it's a little bit more — honestly — mysterious," Greninger says.
Solving that mystery could help scientists improve the vaccines to prevent more breakthrough infections. Booster shots might become part of the answer down the road, they say.
The CDC is continuing to monitor breakthrough coronavirus infections "for clustering by patient demographics, geographic location, time since vaccination and vaccine type or lot number." In addition, the agency is studying specimens of virus from people who experience breakthrough infections, including conducting genetic studies to see if any particular variants are more likely to be involved than others.
For her part, Eatman is still glad she got vaccinated. She recovered after about 10 days. But she has friends who weren't nearly as lucky — friends who hadn't gotten vaccinated.
"We've had people at our church — a couple of them," Eatman says. In one case, "once she got COVID, it took her fast. And then another lady, just a little bit older than I am, wound up in the hospital, had the pneumonia, in ICU, out of ICU, back in ICU. And she went home to be with the Lord."
- Coronavirus Cases Are Rising Again. See How Your State Is Doing
- More Colleges Say They'll Require Students To Have COVID-19 Vaccines For Fall
- OPINION: 5 Ways To Make The Vaccine Rollout More Equitable
- Studies Confirm Racial, Ethnic Disparities In COVID-19 Hospitalizations And Visits
- Vaccine Refusal May Put Herd Immunity At Risk, Researchers Warn
- Scientists Race To Develop Next Generation Of COVID Vaccines
- Study: COVID-19 Vaccine Is Safe During Pregnancy And May Protect Baby, Too